151 related articles for article (PubMed ID: 30343311)
1. Serum Preptin and Amylin Levels with Respect to Body Mass Index in Polycystic Ovary Syndrome Patients.
Şentürk Ş; Hatirnaz S; Kanat-Pektaş M
Med Sci Monit; 2018 Oct; 24():7517-7523. PubMed ID: 30343311
[TBL] [Abstract][Full Text] [Related]
2. Patatin-like phospholipase domain containing 3-gene (adiponutrin), preptin, kisspeptin and amylin regulates oocyte developmental capacity in PCOS.
Celik N; Aydin S; Ugur K; Yardim M; Acet M; Yavuzkir S; Sahin İ; Celik O
Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):7-12. PubMed ID: 30672430
[TBL] [Abstract][Full Text] [Related]
3. Preptin in women with polycystic ovary syndrome.
Mierzwicka A; Kuliczkowska-Plaksej J; Kolačkov K; Bolanowski M
Gynecol Endocrinol; 2018 Jun; 34(6):470-475. PubMed ID: 29374985
[TBL] [Abstract][Full Text] [Related]
4. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
[TBL] [Abstract][Full Text] [Related]
5. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
6. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
8. Serum Preptin and Amylin Values in Psoriasis Vulgaris and Behçet's Patients.
Dogan FB; Cicek D; Aydin S; Dertlioglu SB; Halisdemir N; Ucak H; Demir B; Erden I
J Clin Lab Anal; 2016 Mar; 30(2):165-8. PubMed ID: 25545917
[TBL] [Abstract][Full Text] [Related]
9. The Predictive Role of Serum Cystatin C Levels in Polycystic Ovary Syndrome in Adolescents.
Çınar M; Aksoy RT; Güzel Aİ; Tokmak A; Çandar T; Taşçı Y
J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):353-6. PubMed ID: 26740281
[TBL] [Abstract][Full Text] [Related]
10. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
[TBL] [Abstract][Full Text] [Related]
11. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
[TBL] [Abstract][Full Text] [Related]
12. The relationship between polycystic ovary syndrome, glucose tolerance status and serum preptin level.
Bu Z; Kuok K; Meng J; Wang R; Xu B; Zhang H
Reprod Biol Endocrinol; 2012 Feb; 10():10. PubMed ID: 22309801
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like factor 3 -- a new hormone related to polycystic ovary syndrome?
Szydlarska D; Grzesiuk W; Trybuch A; Kondracka A; Kowalik I; Bar-Andziak E
Endokrynol Pol; 2012; 63(5):356-61. PubMed ID: 23115068
[TBL] [Abstract][Full Text] [Related]
14. The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome.
Yucel A; Noyan V; Sagsoz N
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):81-6. PubMed ID: 16337726
[TBL] [Abstract][Full Text] [Related]
15. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
[TBL] [Abstract][Full Text] [Related]
17. Apelin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
Altinkaya SÖ; Nergiz S; Küçük M; Yüksel H
Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():168-72. PubMed ID: 24642195
[TBL] [Abstract][Full Text] [Related]
18. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA
Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
Thierry van Dessel HJ; Lee PD; Faessen G; Fauser BC; Giudice LC
J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
